InvestGPT
Discover
Watchlist
Market Movers
Al Stock Picker
Smart Signals
History

to keep track of your history and unlock additional search opportunities.

Pricing Plans
Portfolio Toolbox
Kavout Log in

HRTS

Tema GLP-1 Obesity & Cardiometabolic ETF · NAS

  • Category Health Care
  • Expense Ratio 0.75%
  • Listing Date Nov 21, 2023
  • Volume 10,439.0
  • Market Cap (AUM) $60.93M

Performance

-2.61%

1W

-1.1%

1M

-2.33%

3M

-13.27%

6M

+2.94%

YTD

-8.73%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • Vertex Pharmaceuticals IncorporatedVRTX6.18%
  • Eli Lilly and CompanyLLY5.71%
  • Amgen Inc.AMGN5.48%
  • Novo Nordisk A/S Class BNOVO.B5.25%
  • DexCom, Inc.DXCM3.84%
  • Cytokinetics, IncorporatedCYTK3.56%
  • Insulet CorporationPODD3.30%
  • Mereo BioPharma Group plc Sponsored ADRMREO3.24%
  • Edwards Lifesciences CorporationEW3.16%
  • BridgeBio Pharma, Inc.BBIO2.96%
Advanced Technical Analysis

Technical Analysis of HRTS 2025-03-13

The stock indicators reflect a bearish sentiment, with a Moving Average Score of 0 indicating strong downward momentum, an Oscillators Score of 37 suggesting weak bullish potential, and a Technical Score of 18 reinforcing the overall negative outlook. Collectively, these scores indicate a challenging environment for the stock, warranting caution...
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.